Gerresheimer Achieves Sales Targe... (lass xn-location Brazil a newproduction...)

Gerresheimer Achieves Sales Target for 2009

Date:2/9/2010

lass="xn-location">Brazil, a new production facility for insulin pen systems is planned for early 2010.

Outlook for 2010

The negative effects of the global financial and economic crisis should gradually abate and a revival in demand is now likely.

While Gerresheimer again expects growth for the pharma market, the outlook for cosmetics and Life Science Research is more difficult. Against this background the Management Board expects for the current financial year a sales increase of 2 to 4 percent (in relation to adjusted sales excluding Technical Plastic Systems of EUR970.8m) and an improved operating margin (Adjusted EBITDA Margin) of around 19.5 percent. Investment will total around EUR75m to 80m.

About Gerresheimer

Gerresheimer employs around 9,400 people in 40 locations in Europe, Americas and Asia. In the financial year 2009, worldwide sales totaled EUR1 billion. The product portfolio ranges from pharmaceutical vials made of glass and plastic through to complex drug-delivery systems for the pharma & healthcare industry. These include sterile syringes, inhalers and other system-based approaches for safe dosage and application of medications. The Group enjoys a leading position in markets which are characterized by high technical and regulatory barriers.

Group Key Figures (IFRS; Financial Year end November 30)

in EUR million FY 2009 FY 2008 %
Sales 1,000.2 1,060.1 -5.7
Group sales excluding
Technical Plastics[1] 970.8 985.9 -1.5

Adjusted EBITDA[2] 185.9 206.4 -9.9
in % of sales 18.6 19.5

Adjusted EBITDA[2] excluding 186.2
'/>"/>
SOURCE Gerresheimer AG
Copyright©2010 PR Newswire.
All rights reserved
0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Gerresheimer has Passed the Turning Point
2. Mirixa Australia Achieves Six Month Milestones
3. Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
4. NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
5. EUCODIS Bioscience Achieves Development Milestone in Second Collaboration With Lohmann Animal Health
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Micromets Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. Glycotex Investigational Compound GLYC-101 Achieves Accelerated Wound Closure Based on Interim Analysis
10. Semafore Achieves a Preclinical Milestone with SF2626, a PI3K-MEK Dual Pathway Kinase Inhibitor
11. Prescient Medical Achieves Milestones in Clinical Studies of vProtect(TM) Luminal Shield

Post Your Comments:

(Date:5/17/2013)... 17, 2013 Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... at the UBS Global Healthcare Conference in New ... 22 nd at 11 a.m. Eastern Time. To listen ... please visit the Investor Relations section of the Company,s Web ... for 14 days after the event. About Orexigen® ...

(Date:5/17/2013)... Biotechnology Inc. ("Sony") today announced the launch of the new ... Sony will also be exhibiting its newly rebranded reagent portfolio. ... EC800 flow cytometer, and new SP6800 Spectral Analyzer will be ... held at the San Diego Convention ... May 20 - 22. The 8-well strip ...

(Date:5/17/2013)... Research explores data on ... also to be presented ... the global specialty biopharmaceutical company, announces that it will ... American Psychiatric Association (APA) 166th Annual Meeting in ... being presented represent Shire,s ongoing commitment to the clinical ...

[0] Orexigen Therapeutics to Present at the UBS Global Healthcare Conference [0] Sony Delivers New Technology for Science to CYTO 2013 [0] Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting

... increasingly are applying genomics technologies to toxicology research to ... a variety of organ systems, reports Genetic Engineering ... especially interested in figuring out a new compound,s mechanism ... according to the November 15 issue of GEN ...

... Nov. 18 Arlington Medical Resources (AMR), a,provider of ... finds that over $10 million of CSL Behring,s Privigen ... 2008. Privigen is the newest,brand of intravenous immune globulin ... IVIG is a product created from the blood plasma ...

Cached Medicine Technology:GEN Reports on the Trend Toward Predictive Toxicogenomics 2 Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2

GEN Reports on the Trend Toward Predictive Toxicogenomics Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008

(Date:5/18/2013)... Utah (PRWEB) May 18, 2013 ... on insurance agents’ role in Marketplaces . ... to traditional employer sponsored health benefits, is the ... and health reimbursement arrangements . , ... Health and Human Services (HHS) recently released a ...

(Date:5/18/2013)... 2013 The “World Healthcare IT Market: ... the major market drivers, restraints, and opportunities in North ... Browse , 89 market data ... on "Healthcare IT Market" , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html ... reports. , The global healthcare IT market is expected ...

(Date:5/18/2013)... (PRWEB) May 18, 2013 As ... courts throughout the country, Bernstein Liebhard LLP notes that ... patients often suffer tissue damage before they experience any ... according to Science Daily will appear in the Journal ... recipients underwent MRI screens of their hips. The ...

(Date:5/18/2013)... 2013 The “Sleep Apnea Diagnostic & ... Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] ... analyzes and studies the major market drivers, restraints, and ... the World. , Browse , ... Figures , 318 pagesand in-depth TOC ...

(Date:5/18/2013)... The Ayurvedic practitioner program will be ... the West. Program is available in Mexico via Live ... healing modality practiced for over 5,000 years. In Ayurvedic ... health begins when an individual lives in harmony with ... needs. Ayurveda aims to heal an individual in all ...

Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2 Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3 Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4 Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2 Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3 Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2 Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3 Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4 Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2 Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3 Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2

[0] Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces [0] Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets [0] Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients [0] Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets [0] Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West

... new discovery may lead to more effective screening and treatment ... tumor-like growths and a high risk of developing specific cancers. ... issue of the American Journal of Human Genetics, ... alternate susceptibility gene for Cowden syndrome (CS) and related disorders. ...

... MRIs to skyrocket over the next five ... years, according to Millennium Research Group, WALTHAM, ... US Markets for Women,s Health Imaging Systems 2008 report,the ... magnetic,resonance imaging (MRI) coils, dedicated breast MRI systems, and,breast-specific ...

... of Diabetes Educators (AADE) today announced results from ... between people with diabetes that require insulin injections ... results, 33 percent of respondents have experienced some ... percent strongly agreed/25 percent somewhat agreed), 14 percent ...

... Research Laboratories,Inc. (CRL) announced today that it has ... follow-up libraries. Such ultra-fast,hit-to-lead libraries are now produced ... three to six days which enables critical acceleration ... new industry benchmark.,This state-of-the-art high-throughput chemistry technology was ...

... Benefit Services, Inc., today announced the release of their 2008 Benefit ... trends and strategies. , ... Syosset, NY (PRWEB) August ... Inc., today announced the release of their 2008 Benefit Plan Report, ...

... The CDC,s revised statistics regarding new HIV infections emphasizes the critical ... Startling statistics show 25% of persons infected don,t know they carry ... ... New cases of HIV infection in the U.S. have been underestimated ...

Cached Medicine News:Health News:Beyond PTEN: Alternate genes linked to breast, thyroid and kidney cancer predisposition 2 Health News:Adjunct Breast Imaging Market to Increase by Almost 28% per Year Through 2013 2 Health News:New survey explores the impact of insulin injections on people with diabetes 2 Health News:New survey explores the impact of insulin injections on people with diabetes 3 Health News:New survey explores the impact of insulin injections on people with diabetes 4 Health News:ChemBridge Research Laboratories, Inc. (CRL) has Established an Industry Record and Benchmark in Hit-to-Lead Libraries Turn-around Time 2 Health News:Average Annual Medical Premium Costs Increased 6%, Says 2008 Benefit Plan Report from C&B Consulting 2 Health News:Why Affordable HIV Testing Is More Important Than Ever: "HIV Epidemic 40% Higher Than Estimates" 2 Health News:Why Affordable HIV Testing Is More Important Than Ever: "HIV Epidemic 40% Higher Than Estimates" 3

Beyond PTEN: Alternate genes linked to breast, thyroid and kidney cancer predisposition Adjunct Breast Imaging Market to Increase by Almost 28% per Year Through 2013 New survey explores the impact of insulin injections on people with diabetes ChemBridge Research Laboratories, Inc. (CRL) has Established an Industry Record and Benchmark in Hit-to-Lead Libraries Turn-around Time Average Annual Medical Premium Costs Increased 6%, Says 2008 Benefit Plan Report from C&B Consulting Why Affordable HIV Testing Is More Important Than Ever: "HIV Epidemic 40% Higher Than Estimates"

Classic Trial Frames UB3 that has long set the standard....

... This quality Universal Trial Frame comes at a very attractive ... Temple angle, Temple length 4 1/8" to 5 1/2" ... angle 0 to 30, PD adjustable 24 to 40mm ... Axial calibration on each lens: left - 120 to 0 ...

Sickle blade. Flat stock myringotomy blade....

... offer the superior cutting advantages of ... the exclusive Rib-Back design for greater ... producer offer the wide selection of ... Every blade is packaged in a ...

Medicine Products:

Classic Trial Frames UB3 Adult Trial Frame Sickle Blade Rib Back